Fennec Pharmaceuticals Net Debt Growth & History (FENC)
Fennec Pharmaceuticals's net debt was −$36.8M for fiscal 2025.
View full Fennec Pharmaceuticals company overviewFennec Pharmaceuticals annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$36.8M | −$29.5M | — |
| 2024 | 2024-12-31 | −$7.3M | −$25.0M | — |
| 2023 | 2023-12-31 | $17.7M | $16.6M | +1472.00% |
| 2022 | 2022-12-31 | $1.1M | $17.2M | — |
| 2021 | 2021-12-31 | −$16.1M | — | — |
Fennec Pharmaceuticals quarterly net debt
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | −$36.8M | −$29.5M | — |
| Q3 2025 | 2025-09-30 | −$2.6M | $5.6M | — |
| Q2 2025 | 2025-06-30 | $659,000 | $11.9M | — |
| Q1 2025 | 2025-03-31 | −$3.3M | $16.5M | — |
| Q4 2024 | 2024-12-31 | −$7.3M | −$25.0M | — |
| Q3 2024 | 2024-09-30 | −$8.2M | −$21.5M | — |
| Q2 2024 | 2024-06-30 | −$11.3M | −$21.7M | — |
| Q1 2024 | 2024-03-31 | −$19.8M | −$26.6M | — |
| Q4 2023 | 2023-12-31 | $17.7M | $16.6M | +1472.00% |
| Q3 2023 | 2023-09-30 | $13.3M | $18.0M | — |
| Q2 2023 | 2023-06-30 | $10.4M | $20.3M | — |
| Q1 2023 | 2023-03-31 | $6.8M | $20.0M | — |
| Q4 2022 | 2022-12-31 | $1.1M | $17.2M | — |
| Q3 2022 | 2022-09-30 | −$4.8M | — | — |
| Q2 2022 | 2022-06-30 | −$9.9M | — | — |
| Q1 2022 | 2022-03-31 | −$13.3M | — | — |
| Q4 2021 | 2021-12-31 | −$16.1M | — | — |
Fennec Pharmaceuticals net debt trends
Between the periods ended 2021-12-31 and 2025-12-31, Fennec Pharmaceuticals's net debt decreased from −$16.1M to −$36.8M, a change of −$20.7M. The latest reported quarter, Q4 2025, shows −$36.8M.
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Fennec Pharmaceuticals source filings ↗